HLA-DQA1*05 Associates With Anti-Tumor Necrosis Factor Immunogenicity and Low Adalimumab Trough Concentrations in Inflammatory Bowel Disease Patients From the SERENE Ulcerative Colitis and Crohn’s Disease Studies

Authors

Xiuwen Zheng (ORCID: https://orcid.org/0000-0002-1390-0708)
Mark Reppell (ORCID: https://orcid.org/0000-0001-7992-4537)
Valerie Pivorunas (ORCID: https://orcid.org/0000-0001-6647-8494)
Ingeborg Dreher
Jonas Blaes
Tobias Haslberger
Heath Guay (ORCID: https://orcid.org/0000-0002-6754-9589)
Nizar Smaoui
Elina Regan

Institutions

Ludwigshafen University of Business and Society (DE)
AbbVie (United States) (US)
AbbVie (Germany) (DE)
Klinikum Ludwigshafen (DE)

Publication Details

Journal: Journal of Crohn s and Colitis
Published: 2024-08-20
DOI: https://doi.org/10.1093/ecco-jcc/jjae129
Citations: 9
Primary Topic: Inflammatory Bowel Disease
Type: article
Field-Weighted Citation Impact: 4.95

Funders

AbbVie

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

HLA-DQA1*05 Associates With Anti-Tumor Necrosis Factor Immunogenicity and Low Adalimumab Trough Concentrations in Inflammatory Bowel Disease Patients From the SERENE Ulcerative Colitis and Crohn’s Disease Studies

Xiuwen Zheng, Mark Reppell, Valerie Pivorunas, Ingeborg Dreher et al.

Aug 20, 2024

9 citations

Journal of Crohn s and Colitis

Inflammatory Bowel Disease

4.95

article

HLA-DQA1*05 Associates With Anti-Tumor Necrosis Factor Immunogenicity and Low Adalimumab Trough Concentrations in Inflammatory Bowel Disease Patients From the SERENE Ulcerative Colitis and Crohn’s Disease Studies

Xiuwen Zheng, Mark Reppell, Valerie Pivorunas, Ingeborg Dreher, Jonas Blaes, Tobias Haslberger, Heath Guay, Nizar Smaoui, Elina Regan

August 20, 2024article en

9 citations

Abstract

No abstract available for this paper.

Journal of Crohn s and ColitisVol. 19(1)

Ludwigshafen University of Business and Society (DE), AbbVie (United States) (US), AbbVie (Germany) (DE), Klinikum Ludwigshafen (DE)

AbbVie

Good health and well-being

Openalex Percentile: Top 5%

Inflammatory Bowel Disease

4.95

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.